Pediatric adenomatous polyposis syndromes: An update

Current Gastroenterology Reports

Volumn 9, Issue 3, 2007, Pages 237-244

  Erdman, Steven H ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; DNA; DNA GLYCOSYLASE MUTY;

ADENOMATOUS POLYP; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CANCER CLASSIFICATION; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; CHILD; CHILDHOOD CANCER; COLON ADENOMA; COLON CANCER; COLON RESECTION; COLORECTAL CANCER; DISEASE SURVEILLANCE; DNA REPAIR; FAMILIAL CANCER; FAMILY HISTORY; GENE MUTATION; GENETIC SCREENING; HUMAN; ILEORECTAL ANASTOMOSIS; MEDICAL CARE; MISMATCH REPAIR; MUTATIONAL ANALYSIS; PATIENT EDUCATION; PHENOTYPE; REVIEW; RISK REDUCTION;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; CHILD; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA GLYCOSYLASES; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; SYNDROME;

EID: 34249875979     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-007-0025-0     Document Type: Review

References (49)

1. Itzkowitz SH, Rochester J: Colonic polyps and polyposis syndromes. In Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management, edn 8. Edited by Feldman M, Friedman LS, Brandt LJ. Philadelphia: WB Saunders; 2006:2720-2725.
2. Vasen HF, Watson P, Mecklin JP, Lynch HT: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999, 116:1453-1456.
3. Lynch HT, Boland CR, Gong G, et al.: Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 2006, 14:390-402.
4. Boland CR, Thibodeau SN, Hamilton SR, et al.: A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998, 58:5248-5257.
5. Umar A, Boland CR, Terdiman JP, et al.: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004, 96:261-268.
6. Jass JR: Hereditary non-polyposis colorectal cancer: The rise and fall of a confusing term. World J Gastroenterol 2006, 12:4943-4950.
7. Lindor NM, Rabe K, Peterson G, et al.: Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005, 293:1979-1985.
8. Mueller-Koch Y, Vogelsang H, Lohse P, et al.: Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 2005, 54:1733-1740.
9. Huang SC, Lavine JE, Boland PS, et al.: Germline characterization of early-aged onset of hereditary non-polyposis colorectal cancer. J Pediatr 2001, 138:629-635.
10. Durno C, Aronson M, Bapat B, et al.: Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. Gut 2005, 54:1146-1150.
11. Muller A, Schackert HK, Lange B, et al.: A novel MSH2 germline mutation in homozygous state in two brothers with colorectal cancers diagnosed at the age of 11 and 12 years. Am J Med Genet 2006, 140A:195-199.
12. Gallinger S, Aronson M, Shayan K, et al.: Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology 2004, 126:576-585.
13. Kraus C, Kastl S, Gunther K, et al.: A proven de novo germline mutation in HNPCC. J Med Genet 1999, 36:919-921.
14. de Jong AE, Hendriks YM, Kleibeuker JH, et al.: Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006 130:665-671.
15. National Comprehensive Cancer Network: v.1.2006 Clinical Practice Guidelines in Oncology - Colorectal Cancer Screening. http://www.nccn.org/professional/physician_gls/PDF/ colorectal_sbreening.pdf. Accessed January 11, 2007.
16. Lindor NM, Petersen GM, Hadley DW, et al.: Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006, 296:1507-1517.
17. Hendriks YM, de Jong AE, Morreau H, et al.: Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin 2006, 56:213-225.
18. Solomon C, Burt RW: APC-associated polyposis conditions. GeneReviews http://www.genetests.org/. Accessed January 11, 2007.
19. Auricchio R, De Rosa M, Quaglietta L, et al.: A dramatic case of early-onset familial adenomatous polyposis. Clin Genet 2005, 67:104-106.
20. Galiatsatos P, Foulkes WD: Familial adenomatous polyposis Am J Gastroenterol. 2006, 101:385-398.
21. Akiyama T, Kawasaki Y: Wnt signaling and the actin cytoskeleton. Oncogene 2006, 25:7538-7544.
22. Dikovskaya D, Schiffmann D, Newton IP, et al.: Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis. J Cell Biol 2007, 176:183-195.
23. Grady WM, Markowitz SD: Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet 2002, 3:101-128.
24. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
25. Trimbath A Giardiello FM: Genetic testing and counseling for hereditary colorectal cancer [review]. Aliment Pharmacol Ther 2002, 16:1843-1857.
26. Bussey HJR: Relationship to carcinoma. In Familial Polyposis Coli: Family Studies, Histopathology, Differential Diagnosis, and Results of Treatment. Baltimore: The Johns Hopkins University Press; 1975:47-50.
27. Iwama T, Tamura K, Morita T, et al.: A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Int J Clin Oncol 2004, 9:308-316.
28. Friedl W, Caspari R, Sengteller M, et al.: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 2001, 48:515-521.
29. Bülow S: Results of national registration of familial adenomatous polyposis. Gut 2003, 52:742-746.
30. Church JM, McGannon E, Burke C, Clark B: Teenagers with familial adenomatous polyposis: what is their risk for colorectal cancer? Dis Colon Rectum 2002, 45:887-889.
31. Debinski HS, Love S, Spigelman AD, et al.: Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology 1996, 110:1028-1030.
32. Brosens LA, Keller JJ, Offerhaus GJ, et al.: Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut 2005, 54:1034-1043.
33. Galle TS, Juel K, Bulow S: Causes of death in familial adenomatous polyposis. Scand J Gastroenterol 1999, 34:808-812.
34. Attard TM, Cuffari C, Tajouri T, et al.: Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol 2004, 99:681-686.
35. Morpurgo E, Vitale GC, Galandiuk S, et al.: Clinical characteristics of familial adenomatous polyposis and management of duodenal adenomas. J Gastrointest Surg 2004, 8:559-564.
36. Hirschman BA, Pollock BH, Tomlinson GE: The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds. J Pediatr 2005, 147:263-266.
37. Durno CA, Gallinger S: Genetic predisposition to colorectal cancer: new pieces in the pediatric puzzle. J Pediatr Gastroenterol Nutr 2006, 43:5-15.
38. Wu JS, Paul P, McGannon EA, Church JM: APC genotype, polyp number, and surgical options in familial adenomatous polyposis. Ann Surg 1998, 227:57-62.
39. Bülow C, Vasen H, Jarvinen H, et al.: Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis. Gastroenterology 2000, 119:1454-1460.
40. Church J: Ileoanal pouch neoplasia in familial adenomatous polyposis: an underestimated threat. Dis Colon Rectum 2005, 48:1708-1713.
41. Al-Tassan N, Chmiel NH, Maynard J, et al.: Inherited variants of MYH associated with somatic G:C-->T: A mutations in colorectal tumors. Nat Gene 2002, 30:227-232.
42. Sampson JR, Jones S, Dolwani S, Cheadle JP: MutYH (MYH) and colorectal cancer. Biochem Soc Trans 2005, 33:679-683.
43. Aretz S, Uhlhaas S, Goergens H, et al.: MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer 2006, 119, 807-814.
44. Sampson JR, Dolwani S, Jones S, et al.: Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 2003, 362:39-41.
45. Croitoru ME, Cleary SP, Nando Di Nicola N, et al.: Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 2004, 96:1631-1634.
46. Ponti G, Ponz de Leona M, Maffeia S, et al.: Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin Genet 2005, 68:442-447.
47. Jo WS, Bandipalliam P, Shannon KM, et al.: Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol 2005, 3:1022-1028.
48. Farrington SM, Tenesa A, Barnetson R et al.: Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet 2005, 77:112-119.
49. Webb EL, Rudd MF, Houlston RS: Colorectal cancer risk in monoallelic carriers of MYH variants [letter]. Am J Hum Genet 2006, 8:771.